Validation of a novel treatment for glioblastoma
Ended Project Grant Awarded
- Award ID
- R41CA186435
- Recipient
-
Curtana Pharmaceuticals Inc. UEI PM1PJ3RUXZ54
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $225,000
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Quick answers
Who received award R41CA186435?
R41CA186435 was awarded to Curtana Pharmaceuticals Inc. by National Institutes of Health (Department of Health and Human Services) on September 24, 2014.
How much is award R41CA186435 worth?
$225,000 has been obligated on R41CA186435.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award